Longitudinal effects of Nucleos(t)ide analogue therapy in chronic hepatitis B patients and the utility of non-invasive fibrosis markers during treatment: A single-center experience for up to 17 years

Authors:

Abstract
No abstract available
Funding Information
  • National Institutes of Health

This publication has 39 references indexed in Scilit: